Case Studies

The cases presented herein demonstrate the power of Sanguine's innovative patient recruitment strategies and nationwide mobile phlebotomy network. This model has proven successful in reducing lead times and efficiently delivering reliable biospecimen to researchers when other sources have proven insufficient.

Hopefully these studies will resonate with your organization's needs, and illustrate Sanguine's superior recruiting and specimen collection capabilities required to make your projects successful.

Sickle Cell Disease

A sickle cell disease (SCD) research lab at a top 10 pharmaceutical company required blood samples for their biomarker discovery project.

Read More

Crohn's Disease

A Korean biopharmaceutical company urgently needed biospecimen from subjects with Crohn's Disease to complete data collection for a rapidly approaching regulatory filing deadline.

Read More

Multiple Sclerosis

A major biotechnology company required same-day delivery of blood specimens for a Multiple Sclerosis (MS) study.

Read More

Cystic Fibrosis

A top 10 pharmaceutical company approached Sanguine with a cystic fibrosis (CF) study involving an interesting caveat regarding inclusion criteria based on recent international travel.

Read More

Rare Minority Population

A top-5 contract research organization was unable to obtain a healthy Japanese control population for a study being conducted for their client.

Read More

Multiple Sclerosis: Longitudinal

A boutique CRO was unsuccessful at sourcing PBMCs via their academic clinical collaborator for a Multiple Sclerosis (MS) longitudinal study involving 6 MS subjects and 6 age-, sex- and ethnicity-matched controls.

Read More